We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.56%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.07B
AUM Growth
-$240M
(-18%)
Cap. Flow
-$251M
Cap. Flow
% of AUM
-23.42%
Top 10 Holdings %
Top 10 Hldgs %
45.14%
Holding
50
New
11
Increased
5
Reduced
17
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sotera Health
SHC
|
+$41.3M |
| 2 |
Microsoft
MSFT
|
+$26.5M |
| 3 |
Insulet
PODD
|
+$25.5M |
| 4 |
Clarivate
CLVT
|
+$23.5M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Well
AMWL
|
+$81.4M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$66M |
| 3 |
Merck
MRK
|
+$48.2M |
| 4 |
Caesars Entertainment
CZR
|
+$41.5M |
| 5 |
Incyte
INCY
|
+$35.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.4% |
| 2 | Technology | 21.97% |
| 3 | Consumer Discretionary | 17.4% |
| 4 | Financials | 5.8% |
| 5 | Communication Services | 5.19% |
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2021 Portfolio in Review
As of Q1 2021, Bridger Management held 50 positions worth $1.07B, down 18% from $1.31B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Bridger Management withdrew a net $251M in Q1 2021, closing 8 positions and reducing 17 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $66M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 49% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in Sotera Health worth $38.9M.
- Bridger Management's largest Q1 2021 buy was Sotera Health: 1,559,828 shares worth $38.9M.
- Bridger Management added most to Frontdoor in Q1 2021, an estimated $6.64M increase.
- Bridger Management's biggest Q1 2021 reduction was American Well, cutting an estimated $81.4M.
- Bridger Management fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $66M.
- Bridger Management's ten largest holdings make up 45% of its $1.07B portfolio in Q1 2021.
- Bridger Management opened 11 new positions and closed 8 in Q1 2021.
- Bridger Management's portfolio value fell 18% quarter-over-quarter to $1.07B.
Based on Bridger Management's 13F filing for Q1 2021, filed 14 May 2021.